Translational Development AcTDACU
13F holders, Q3 2025 (September 30)7holders −2
0new positions
2sold out
1famous investor
$10.47avg. 13F price*
At the end of Q3 2025, 7 institutions reported holding Translational Development Ac (TDACU) in their 13F filings, down 2 from Q2 2025. 0 opened new positions and 2 sold out. The largest holders were Alberta Investment Management Corp ($6.2M), Calamos Advisors LLC ($4.0M) and D. E. Shaw & Co. ($3.6M). One famous investor held it David E. Shaw (0.0% of D. E. Shaw & Co.'s portfolio).
- Company
- Translational Development Ac
- CUSIP
- G9008W121
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $5.0M |
All 13F filers, Q2 2025 → Q3 2025: 1,559 shares bought and 883,325 shares sold, net −881,766 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 7 holders
| Alberta Investment Management Corp | 0.05% | No change | 600,000 | $6.2M |
| Calamos Advisors LLC | 0.02% | No change | 375,000 | $4.0M |
| D. E. Shaw & Co. | 0.00% | No change | 350,000 | $3.6M |
| Rivernorth Capital Management, LLC | 0.06% | Reduce -80.0% | 100,000 | $1.0M |
| Yakira Capital Management, Inc. | 0.24% | No change | 60,000 | $628K |
| Flow Traders U.S. LLC | 0.01% | Add +11.0% | 15,787 | $162K |
| UBS Group AG | 0.00% | No change | 8,330 | $86K |
"% of holder's portfolio" is TDACU's weight in each manager's 13F, not the share of Translational Development Ac the manager owns.